Supernus Pharmaceuticals (SUPN) Gross Profit Growth (1y) (2014 - 2026)
Supernus Pharmaceuticals (SUPN) Gross Profit Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 2.43% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -8.36% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -5.56% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -3.83% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 9.27% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 38.19% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 11.92% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.67 Bn | 2.30 Bn | 185.39 Mn | 24.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.74% |
| Dec 31, 2025 | 27.36% |
| Sep 30, 2025 | 9.51% |
| Jun 30, 2025 | -1.19% |
| Mar 31, 2025 | 5.28% |
| Dec 31, 2024 | 2.33% |
| Sep 30, 2024 | 17.74% |
| Jun 30, 2024 | 31.39% |
| Mar 31, 2024 | -2.28% |
| Dec 31, 2023 | 0.22% |
| Sep 30, 2023 | -11.35% |
| Jun 30, 2023 | -23.48% |
| Mar 31, 2023 | -3.17% |
| Dec 31, 2022 | 1.63% |
| Sep 30, 2022 | 16.18% |
| Jun 30, 2022 | 28.63% |
| Mar 31, 2022 | 16.03% |
| Dec 31, 2021 | 13.62% |
| Sep 30, 2021 | -2.52% |
| Mar 31, 2021 | 27.70% |